CIA
DXCM icon

Concurrent Investment Advisors’s DexCom DXCM Stock Holding History

Concurrent Investment Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$416K Buy
6,624
+664
+11% +$46.2K ﹤0.01% 1305
2025
Q4 		$396K Buy
5,960
+1,897
+47% +$123K ﹤0.01% 1249
2025
Q3 		$273K Sell
4,063
-199
-5% -$15.7K ﹤0.01% 1194
2025
Q2 		$372K Buy
+4,262
New +$334K 0.01% 966
2024
Q3 		– Sell
-1,847
Closed -$209K – 1112
2024
Q2 		$209K Buy
1,847
+204
+12% +$25.8K 0.01% 864
2024
Q1 		$228K Sell
1,643
-307
-16% -$38.6K 0.01% 756
2023
Q4 		$242K Buy
+1,950
New +$199K 0.01% 717

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Concurrent Investment Advisors's DXCM Position: Q1 2026 in Review

Concurrent Investment Advisors increased its DexCom (DXCM) stake by 11% in Q1 2026, buying an estimated $46.2K and bringing the position to 6,624 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

Concurrent Investment Advisors first reported a position in DXCM in Q4 2023 and has held it in 7 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Concurrent Investment Advisors held 6,624 shares of DexCom worth $416K as of Q1 2026.
  • Concurrent Investment Advisors bought 664 DexCom shares in Q1 2026, an estimated $46.2K.
  • DexCom made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #1305 holding.
  • Concurrent Investment Advisors first reported a position in DexCom in Q4 2023 and has held it in 7 quarters since.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.